Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alps B. J., Hill M., Johnson E. S., Wilson A. B. Autonomic blocking properties of Wy 21901. Br J Pharmacol. 1970 Sep;40(1):153P–153P. [PMC free article] [PubMed] [Google Scholar]
- Alps B. J., Hill M., Johnson E. S., Wilson A. B. Quantitative analysis on isolated organs of the autonomic blocking properties of indoramin hydrochloride (Wy 21901). Br J Pharmacol. 1972 Jan;44(1):52–62. doi: 10.1111/j.1476-5381.1972.tb07237.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Antcliff A. C., Bouhoutsos J., Martin P., Morris T. A plethysmographic study of the effect of tetranicotinoylfructose (Bradilan) on digital blood flow in primary and secondary Raynaud's phenomenon. Angiology. 1974 May;25(5):312–316. doi: 10.1177/000331977402500503. [DOI] [PubMed] [Google Scholar]
- Collis M. G., Alps B. J. The evaluation of the alpha-adrenoceptor blocking action of indoramin, phentolamine and thymoxamine on the rat and guinea-pig isolated mesenteric vasculature and aortic spiral preparations. J Pharm Pharmacol. 1973 Aug;25(8):621–628. doi: 10.1111/j.2042-7158.1973.tb10648.x. [DOI] [PubMed] [Google Scholar]
- Fares C. M., Milliken J. C. The effect of parenteral indoramin on peripheral blood flow in patients with Raynaud's disease or atherosclerosis associated with intermittent claudication. Curr Med Res Opin. 1974;2(2):57–62. doi: 10.1185/03007997409114245. [DOI] [PubMed] [Google Scholar]